In vitro antiviral activity of some uridine derivatives of 2-deoxy sugars against classical swine fever virus

Antiviral Research

Volumn 86, Issue 2, 2010, Pages 154-162

  Krol, Ewelina ^a   Wandzik, Ilona ^b   Szeja, Wieslaw ^b   Grynkiewicz, Grzegorz ^c   Szewczyk, Boguslaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b SILESIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^c INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

Author keywords

Classical swine fever virus; Glycoproteins; Glycosylation inhibition; Tunicamycin derivatives

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; IW 3; IW 7; TUNICAMYCIN; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; GROWTH INHIBITION; IC 50; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; VIRUS INHIBITION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL SURVIVAL; CLASSICAL SWINE FEVER VIRUS; DEOXY SUGARS; DOSE-RESPONSE RELATIONSHIP, DRUG; INHIBITORY CONCENTRATION 50; MICROBIAL SENSITIVITY TESTS; SPODOPTERA; SWINE; URIDINE; VIRAL PROTEINS;

CLASSICAL SWINE FEVER VIRUS; HEXAPODA; MAMMALIA; PESTIVIRUS;

EID: 77951297092     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2010.02.314     Document Type: Article

References (54)

1. Altmann F., März L. Processing of asparagine-linked oligosaccharides in insect cells: evidence for α-mannosidase II. Glycoconj. J. 1995, 12:150-155.
2. Asano N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 2003, 13:93R-104R.
3. Becher P., Avalos Ramirez R., Orlich M., Cedillo Rosales S., König M., Schweizer M., Stalder H., Schirrmeier H., Thiel H.J. Genetic and antigenic characterization of novel pestivirus genotypes: implications for classification. Virology 2003, 311:96-104.
4. Beer M., Reimann I., Hoffmann B., Depner K. Novel marker vaccines against classical swine fever. Vaccine 2007, 25:5665-5670.
5. Björklund H.V., Stadejek T., Vilcek S., Belák S. Molecular characterization of the 3′ noncoding region of classical swine fever virus vaccine strains. Virus Genes 1998, 16:307-312.
6. Bourke C.A., Carrigan M.J. Experimental tunicamycin toxicity in cattle, sheep and pigs. Aust. Vet. J. 1993, 70:188-189.
7. Breton C., Snajdrová L., Jeanneau C., Koca J., Imberty A. Structures and mechanisms of glycosyltransferases. Glycobiology 2006, 16:29R-37R.
8. Chapel C., Garcia C., Bartosch B., Roingeard P., Zitzmann N., Cosset F.-L., Dubuisson J., Dwek R.A., Trépo C., Zoulim F., Durantel D. Reduction of the infectivity of hepatitis C virus pseudoparticles by incorporation of misfolded glycoproteins induced by glucosidase inhibitors. J. Gen. Virol. 2007, 88:1133-1143.
9. Duksin D., Mahoney W.C. Relationship of the structure and biological activity of the natural homologues of tunicamycin. J. Biol. Chem. 1982, 257:3105-3109.
10. Durantel D., Branza-Nichita N., Carrouée-Durantel S., Butters T.D., Dwek R.A., Zitzmann N. Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus. J. Virol. 2001, 75:8987-8998.
11. Duvet S., Op De Beeck A., Cocquerel L., Wychowski C., Cacan R., Dubuisson J. Glycosylation of the hepatitis C virus envelope protein E1 occurs posttranslationally in a mannosylphosphoryldolichol-deficient CHO mutant cell line. Glycobiology 2002, 12:95-101.
12. Edwards S., Fukusho A., Lefèvre P.C., Lipowski A., Pejsak Z., Roehe P., Westergaard J. Classical swine fever: the global situation. Vet. Microbiol. 2000, 73:103-119.
13. Elbein A.D. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem. 1987, 56:497-534.
14. Ganges L., Núñez J.I., Sobrino F., Borrego B., Fernández-Borges N., Frías-Lepoureau M.T., Rodríguez F. Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection. Vet. J. 2008, 177:169-177.
15. Greiser-Wilke I., Moennig V. Vaccination against classical swine fever virus: limitations and new strategies. Anim. Health Res. Rev. 2004, 5:223-226.
16. rns is an endoribonuclease with an unusual base specificity. J. Virol. 2004, 78:5507-5512.
17. Jarvis D.L., Finn E.E. Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells. Virology 1995, 212:500-511.
18. Kohsaka S., Mita K., Matsuyama M., Mizuno M., Tsukuda Y. Impaired development of rat cerebellum induced by neonatal injection of the glycoprotein synthesis inhibitor, tunicamycin. J. Neurochem. 1985, 442:406-410.
19. König M., Lengsfeld T., Pauly T., Stark R., Thiel H.J. Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins. J. Virol. 1995, 69:6479-6486.
20. Kornfeld R., Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu. Rev. Biochem. 1985, 54:631-664.
21. Laevens H., Koenen F., Deluyker H., Dekruif A. Experimental infection of slaughter pigs with classical swine fever virus: transmission of the virus, course of the disease and antibody response. Vet. Rec. 1999, 145:243-248.
22. rns based on disulfide bond connectivity and homology modeling reveals an extremely rare vicinal disulfide. J. Virol. 2002, 76:10383-10392.
23. Laude H. Hog cholera virus: art and facts. Ann. Rech. Vet. 1987, 18:127-138.
24. Lazar C., Durantel D., Macovei A., Zitzmann N., Zoulim F., Dwek R.A., Branza-Nichita N. Treatment of hepatitis B virus-infected cells with α-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity. Antiviral Res. 2007, 76:30-37.
25. Luckow V.A., Lee S.C., Barry G.F., Olins P.O. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. J. Virol. 1993, 67:4566-4579.
26. rns of the pestivirus classical swine fever virus lead to virus attenuation. J. Virol. 1999, 73:10224-10235.
27. Montesino R., Toledo J.R., Sanchez O., Zamora Y., Barrera M., Royle L., Rudd P.M., Dwek R.A., Harvey D.J., Cremata J.A. N-glycosylation pattern of E2 glycoprotein from classical swine fever virus. J. Proteome Res. 2008, 8:546-555.
28. Moormann R.J., Warmerdam P.A., van der Meer B., Hulst M.M. Nucleotide sequence of hog cholera virus RNA: properties of the polyprotein encoded by the open reading frame spanning the viral genomic RNA. Vet. Microbiol. 1990, 23:185-191.
29. Nishikawa Y., Xuan X., Otsuka H. Biosynthesis and interaction of glycoproteins E and I of canine herpesvirus. Virus Res. 1999, 61:11-18.
30. Pande A., Carr B.V., Wong S.Y., Dalton K., Jones I.M., McCauley J.W., Charleston B. The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus. Virus Res. 2005, 114:54-62.
31. Parodi A.J. Role of N-oligosaccharide endoplasmic reticulum processing reactions in glycoprotein folding and degradation. Biochem. J. 2000, 348:1-13.
32. Pavio N., Taylor D.R., Lai M.M. Detection of a novel unglycosylated form of hepatitis C virus E2 envelope protein that is located in the cytosol and interacts with PKR. J. Virol. 2001, 76:1265-1272.
33. Plemper R.K., Wolf D.H. Retrograde protein translocation: ERADication of secretory proteins in health and disease. Trends Biochem. Sci. 1999, 24:266-270.
34. Reimann I., Depner K., Trapp S., Beer M. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology 2004, 322:143-157.
35. Risatti G.R., Holinka L.G., Fernandez Sainz I., Carrillo C., Lu Z., Borca M.V. N-linked glycosylation status of classical swine fever virus strain Brescia E2 glycoprotein influences virulence in swine. J. Virol. 2007, 81:924-933.
36. Rümenapf T., Unger G., Strauss J.H., Thiel H.J. Processing of the envelope glycoproteins of pestiviruses. J. Virol. 1993, 67:3288-3294.
37. Sabara M., Babiuk L.A., Gilchrist J., Misra V. Effect of tunicamycin on rotavirus assembly and infectivity. J. Virol. 1982, 43:1082-1090.
38. rns glycoprotein affects virulence in swine. Virology 2008, 370:122-129.
39. Scanlan C.N., Offer J., Zitzmann N., Dwek R.A. Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 2007, 446:1038-1045.
40. Schneider R., Unger G., Stark R., Schneider-Scherzer E., Thiel H.J. Identification of a structural glycoprotein of an RNA virus as a ribonuclease. Science 1993, 261:1169-1171.
41. Schröder M. Endoplasmic reticulum stress responses. Cell. Mol. Life Sci. 2008, 65:862-894.
42. Szewczyk B., Summers D.F. Purification of glycoproteins and their use as immunogens. Methods Mol. Biol. 1998, 80:87-93.
43. Trombetta E.S. The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis. Glycobiology 2003, 13:77R-91R.
44. Tyborowska J., Zdunek E., Szewczyk B. Effect of N-glycosylation inhibition on the synthesis and processing of classical swine fever virus glycoproteins. Acta Biochim. Pol. 2007, 54:813-819.
45. rns or E2 of CSFV. Vaccine 2002, 20:1544-1556.
46. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 2003, 96:367-384.
47. van Rijn P.A., van Gennip H.G., Moormann R.J. An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV). Vaccine 1999, 17:433-440.
48. Wandzik I., Bieg T. Adducts of uridine and glycals as potential substrates for glycosyltansferases. Bioorg. Chem. 2007, 35:401-416.
49. Wang C.J., Sung S.Y., Chen D.S., Chen P.J. N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus. Virology 1996, 220:28-36.
50. Wang Z., Nie Y., Wang P., Ding M., Deng H. Characterization of classical swine fever virus entry by using pseudotyped viruses: E1 and E2 are sufficient to mediate viral entry. Virology 2004, 330:332-341.
51. Weiland E., Stark R., Haas B., Rümenapf T., Meyers G., Thiel H.J. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J. Virol. 1990, 64:3563-3569.
52. Weiland E., Ahl R., Stark R., Weiland F., Thiel H.J. A second envelope glycoprotein mediates neutralization of a pestivirus, hog cholera virus. J. Virol. 1992, 66:3677-3682.
53. Wu S.F., Lee C.J., Liao C.L., Dwek R.A., Zitzmann N., Lin Y.L. Antiviral effects of an iminosugar derivative on flavivirus infections. J. Virol. 2002, 76:3596-3604.
54. Yoshitake N., Xuan X., Otsuka H. Identification and characterization of bovine herpesvirus-1 glycoproteins E and I. J. Gen. Virol. 1997, 78:1399-1403.